ENTA

Enanta Pharmaceuticals, Inc.

Insider Trades

NameValueActionPriceCurrent Price
Capps Kathleen S.See Remarks
$4.6k323 shares
SellDec 5, 2025
$14.23
--
Luly Jay R.Director, Officer: President And CEO
$67k4.7k shares
SellDec 5, 2025
$14.23
--
Kieffer Tara LynnChief Product Strategy Officer
$30k2.1k shares
SellDec 5, 2025
$14.23
--
Or Yat SunChief Scientific Officer
$34k2.4k shares
SellDec 5, 2025
$14.23
--
Luu BrendanChief Business Officer
$20k1.4k shares
SellDec 5, 2025
$14.23
--
Rottinghaus Scott T.Chief Medical Officer
$11k798 shares
SellDec 5, 2025
$14.23
--

News

businesswire.comEnanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)businesswire.comJun 18gurufocus.comEnanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conferencegurufocus.comMay 28businesswire.comEnanta Pharmaceuticals to Present at the Jefferies Global Healthcare Conferencebusinesswire.comMay 28zacks.comEnanta Pharmaceuticals (ENTA) Reports Q2 Loss, Lags Revenue Estimateszacks.comMay 11businesswire.comEnanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026businesswire.comMay 11